Stay updated on Pembrolizumab/Vibostolimab vs Pembrolizumab in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab/Vibostolimab vs Pembrolizumab in Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab/Vibostolimab vs Pembrolizumab in Melanoma Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedFooter area updated to include Revision: v3.3.3 and remove HHS Vulnerability Disclosure and Revision: v3.3.2.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check42 days agoChange DetectedThe history page shows the new revision label v3.3.2 replacing v3.2.0, with minor UI updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check49 days agoChange DetectedAn administrative notice regarding funding and operating status was removed from the page. The remaining trial history and details are unchanged.SummaryDifference0.4%

- Check63 days agoChange DetectedThe new screenshot shows the Record History page with the same list of versions as the old screenshot, indicating a cosmetic update rather than new study information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check78 days agoChange DetectedRecruitment status is updated from active/not recruiting to a current date and updated study/recruitment status, indicating a transition to a new phase and a later timeline.SummaryDifference1%

- Check92 days agoChange Detected- Added a government operations notice and operating details, plus a new v3.2.0 revision. - Removed the previous v3.1.0 revision.SummaryDifference9%

Stay in the know with updates to Pembrolizumab/Vibostolimab vs Pembrolizumab in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab/Vibostolimab vs Pembrolizumab in Melanoma Clinical Trial page.